Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2

Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study

University of Arkansas, Fayetteville · with National Institute on Minority Health and Health Disparities (NIMHD), Carilion Clinic · NCT07842367

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
210
US sites recruiting
3
Study start
September 2026
Record last updated
September 30, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a randomized, double-blind clinical trial involving emergency medicine and internal medicine healthcare providers as participants. The intervention involves the administration of the seasonal influenza vaccine or a saline placebo; this protocol is used in psychoneuro-immunology to simulate a state of mild illness. The primary aim is to examine whether acute inflammation induced by receiving the vaccine affects decision-making on standardized psychological reaction time tasks and questionnaires. Participants attend two laboratory sessions on consecutive days, receive either a seasonal influenza vaccine or a saline placebo at the first session, provide blood samples to measure inflammatory cytokines, and complete a series of standardized assessments of medical decision-making and social attitudes. Participants who received the placebo during the first session will receive the vaccine during the second session.

Overall, the study is designed to examine how adverse provider conditions particularly acute inflammation, burnout, and concerns about one's own health affect provider judgments and healthcare-related decision-making. The primary hypothesis is that providers experiencing greater adverse conditions at the time of research participation would have altered decision-making compared to those experiencing fewer adverse conditions.

Being studied: Influenza vaccine; Placebo

Conditions: Decision-Making; Patient Care; Treatment Decisions

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Healthcare providers currently employed in emergency medicine or internal medicine
  • Must be one of the following: Resident, fellow, attending, or advanced practice provider (NP, PA)
  • Individual is able to travel to the research site for sessions
  • Has not had an acute viral or bacterial infection within the previous 14 days
  • Has not taken an antiviral medication such as Tamiflu in the previous 48 hours
  • Has not taken corticosteroids or immunosuppressants in the previous 30 days

Exclusion Criteria

  • Does not want to receive a flu vaccine as part of the study
  • Has received a flu vaccine this season already (after August of current year)
  • Has had a prior allergic reaction or bad side effect, including Guillain-Barre, due to a flu vaccine or another vaccine
  • Is allergic to eggs or have had an adverse reaction to egg-derived vaccine
  • Is pregnant or suspects a possible pregnancy
  • Has congenital or acquired immunodeficiency such as common variable immunodeficiency (CVID) or HIV/AIDS
  • Has an active hematologic malignancy (like leukemia, lymphoma, myeloma)
  • Has Type 1 diabetes
  • Has Graft vs. Host Disease
  • Uses aspirin, ibuprofen (i.e., NSAIDs), acetaminophen, or naproxen daily
  • Uses corticosteroids or immunosuppressants daily
  • Is currently receiving systemic chemotherapy and/or immunotherapy
  • Has had changes in daily prescription medication in the last 3 months (starting, stopping, changing dose)

Recruiting US locations

  • University of Arkansas for Medical Sciences

    Fayetteville, AR 72703

    Site contact: Roy Kamoga, MD · 785-639-3110 · gkamoga@uams.edu

  • University of New Mexico Health Sciences Center

    Albuquerque, NM 87106

    Site contact: Joe Alcock, MD · 505 272-5062 · JoAlcock@salud.unm.edu

  • Carilion Medical Center

    Roanoke, VA 24016

    Site contact: Michael Wilson, MD · 540-581-5376 · mpwilson1@carilionclinic.org

Study contacts (from the official record)

  • Anastasia Makhanova, PhD · 479-575-8798 · ammakhan@uark.edu
All healthy volunteers studies in Arkansas →
Inflammation and Medical Provider Attitudes, Cognition, and… (NCT07842367) | Bored Studies